Metformin Might Be the Most Suitable Drug for Maintaining Normal Blood Sugar Level
According to a research conducted by the researchers of Johns Hopkins University School of Medicine, metformin is the most preferable drug for the treatment of blood sugar in patients suffering from type-2 diabetes.
When a patient is suffering from type-2 diabetes, his body is not able to use its own insulin effectively to maintain normal blood sugar level.
Though there are 11 types of drugs which have got the approval for the usage to control blood sugar level in type-2 diabetes and Metformin is one of the most widely prescribed drugs.
Researchers found in their study that most of the adults with this type of diabetes consume more than one class of diabetes drugs to achieve optimal blood sugar control.
The team of researchers examined more than 160 studies on the benefits vs. risks of various diabetes drugs and drug combinations and they found that metformin had the best benefit-to-risk profile in controlling blood sugar even if it is consumed with other drugs.
Researcher Wendy L. Bennett of the Johns Hopkins University School of Medicine, and colleagues in the Annals of Internal Medicine, stated, “Although the long-term benefits and harms of diabetes medications remains unclear, the evidence supports the use of metformin as a first-line agent”.
New Zealand News
- Hyundai Motor Corp to create ultra-fast EV charging network E-pit in Korea
- MGE gets six-month extension for South Korea’s Inspire Entertainment Resort development project
- Price of two cheapest trims of Tesla Model 3 electric sedan increased by $500
- Genting Malaysia asks employees to accept reduced pay; executives to take leave without pay
- Tesla to design & build affordable EV in China: Tom Zhu
- Norway’s ICE car sales decline as buyers making shift to EVs
- Pursang launches Retro-inspired E-Track Motorcycle for Euro 14,449 in Netherlands
- ElectReon successfully tests dynamic wireless EV charging system on public road in Sweden
- Volvo to design special Gothenburg Green City Zone for autonomous & related technologies